Christine Ring
CIK: 0001817199
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nurix Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (93 total)
- Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2.9K shares- - Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct4K shares at avg. $26.28$104K - Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.6K shares- - Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.8K shares- - Oct 2, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct5.8K shares at avg. $8.72$50K - Oct 2, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct5.8K shares at avg. $23.19$134K - Sep 2, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct5.8K shares at avg. $8.72$50K - Sep 2, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct400 shares at avg. $26.64$11K - Sep 2, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct5.4K shares at avg. $25.69$138K - Aug 3, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct16.6K shares at avg. $23.05$382K - Aug 3, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct5.8K shares at avg. $8.72$50K - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct3.8K shares at avg. $23.38$90K - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2.9K shares- - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.6K shares- - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.8K shares- - Jul 2, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct5.2K shares at avg. $1.86$10K - Jul 2, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct5.8K shares at avg. $8.72$50K - Jul 2, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct11K shares at avg. $23.56$259K - Jun 25, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct28.9K shares at avg. $20.06$581K - Jun 25, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct13.3K shares at avg. $7.26$97K - Jun 25, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct15.6K shares at avg. $8.72$136K - Jun 2, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct8.1K shares at avg. $16.60$135K - Jun 2, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.4K shares at avg. $1.86$6K - May 4, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct8.1K shares at avg. $16.96$138K - May 1, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct5.4K shares at avg. $16.76$90K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,859 | - | $0 | Direct |
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 3,957 | $26.28 | $103,986 | Direct |
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,573 | - | $0 | Direct |
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,750 | - | $0 | Direct |
| Oct 2, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 5,786 | $8.72 | $50,454 | Direct |
| Oct 2, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 5,786 | $23.19 | $134,149 | Direct |
| Sep 2, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 5,787 | $8.72 | $50,463 | Direct |
| Sep 2, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 400 | $26.64 | $10,655 | Direct |
| Sep 2, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 5,387 | $25.69 | $138,417 | Direct |
| Aug 3, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 16,589 | $23.05 | $382,358 | Direct |
| Aug 3, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 5,787 | $8.72 | $50,463 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 3,847 | $23.38 | $89,954 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,858 | - | $0 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,572 | - | $0 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,750 | - | $0 | Direct |
| Jul 2, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 5,221 | $1.86 | $9,711 | Direct |
| Jul 2, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 5,787 | $8.72 | $50,463 | Direct |
| Jul 2, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 11,008 | $23.56 | $259,366 | Direct |
| Jun 25, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 28,935 | $20.06 | $580,506 | Direct |
| Jun 25, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 13,333 | $7.26 | $96,798 | Direct |
| Jun 25, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 15,602 | $8.72 | $136,049 | Direct |
| Jun 2, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 8,148 | $16.60 | $135,253 | Direct |
| Jun 2, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,422 | $1.86 | $6,365 | Direct |
| May 4, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 8,148 | $16.96 | $138,210 | Direct |
| May 1, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 5,394 | $16.76 | $90,407 | Direct |
1-25 of 93 transactions
About Ring Christine
Ring Christine (SEC CIK 0001817199) files insider reports with the SEC as Chief Legal Officer of Nurix Therapeutics, Inc. (NRIX).
Signal8 holds 33 ownership filings by Ring Christine, all Form 4s, filed between Sep 3, 2024 and Nov 2, 2026. Those filings report 93 transactions, from Sep 3, 2024 to Oct 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ring Christine's filings is in BRISBANE, CA.
Recent filings by Ring Christine
- Oct 30, 2026: Option exercise of NRIX shares (Form 4, code M).
- Oct 30, 2026: Open-market sale of NRIX shares (Form 4, code S).
- Oct 30, 2026: Option exercises of NRIX shares (2 lines, Form 4, code M).
- Oct 2, 2026: Option exercise of NRIX shares (Form 4, code M).
- Oct 2, 2026: Open-market sale of NRIX shares (Form 4, code S).
Other insiders filing for Nurix Therapeutics, Inc. (NRIX)
- van Houte Hans, Chief Financial Officer
- Hansen Gwenn, Chief Scientific Officer
- GREGORY JULIA P, Director
- Silva Paul M, Director
- Saltzman Edward C, Director
- Reinsdorf Judith A, Director